EC 200-037-4
Also known as mercaptopurine, 6-MP, and Purinethol.
In FUZION, TREMFYA 100 mg q8w combined remission rose from 28% at Week 24 to 35% at Week 48; 200 mg q4w rates remained stable and safety was consistent through one year.
